Inderal) (Black, Crowther, Shanks, Smith and Dorhorst, 1964) did not appear to have these undesirable properties. We are reporting our experiences with the clinical use of propranolol with particular reference to its use in arrhythmias, in angina pectoris and during anesthesia, and to its effect on the blood lipid picture and its toxicity.
Material and Methods
Fifty-six patients were treated with propranolol for a variety of conditions. In thirty-eight patients the drug was used for its anti-arrhythmic properties, in sixteen it was given to patients suffering from angina; it was also used in two patients with other conditions. Of the fifty-six patients, forty-seven received propranolol on a long-term basis in a dosage that varied from 30 mg. to 80 mg. daily in 3 or 4 divided doses. Up to 220 mg. was given on a single day. The longest duration of treatment was ten months.
Patients receiving propranolol were checked clinically at frequenlt intervals and blood was taken for certain haematological and biochemioal investigations. These were: white blood count (WBC), transaminases (SGOT, SGPT) (Reitman and Frankel, 1957) , lactic dehydrogenase (LDH) (Wroblewski and LaDue, 1955) , blood urea, bilirubin (by the method of Malloy and Evelyn), alkaline phosphatase (autoanalyser) (Marsh, Fingerhut and Kirsch, 1959) , and thymol turbidity (by the method of MacLaggan).
Eleven of the patients on long-term propranolol were also investigated for changes in certain blood lipid fractions. Three of these patients were receiving the drug for prevention of arrhythmias and the remainder were suffering from angina. The blood samples were taken either fasting from in-patients or were taken at noon from out-patients who had had a light breakfast and rested for half-an-hour before venepuncture. In any one patient, all the samples were either taken as an in-patient or all the samples as an out-patient. Blood was withdrawn from an antecubital vein without proximal constriction of the arm. The lipid fractions measured were as follows: total cholesterol by the method of Zak and Zlatkis (Leffler, 1960) , phospholipids by the modified Bartlett method (Bartlett, 1959) , triglycerides (Handel 4nd Zilversmit, 1957) and free fatty acids by the technique of Dole (1956) . Propranolol has been used during anesthesia in fifty patients by Dr. H. L. T. Thornton and Dr. L. Strunin and we are grateful to them for some details of their results which we report in the section on the use of propranolol in anaesthesia.
Results
Reversion of Arrhythmias to Sinus Rhythm (10 patients) Supraventricular Tachycardia. Ten episodes in five patients have been corrected. In all except one the patients were referred because the tachycardia had proved resistant to tbe usual forms of treatment. Two patients were in congestive cardiac failure due to the arrhythmia which had lasted for three and ten days respectively. In both patients sinus rhythm was restored after one oral dose of propranolol, 10 mg. The Propranolol was found to be useful in slowing the heart rate in certain surgical situations. Tachycardia is produced by adrenaline-containing saline injected locally to define tissue planes and this could be slowed effectively by propranolol. One patient developed reflex tachycardia during surgery in the region of the stellate ganglion and this was slowed by propranolol. The tachycardia of thyrotoxicosis showed some slowing with propranolol, and, if the tachycardia produced by atropine premedications was too marked, propranolol was effective in producing some slowing.
One patient under halothane anasthesia was given a ganglion blocking agent to lower the blood pressure; subsequently 1 mg. of propranolol was given and this produced a marked hypotension which proved difficult to correct.
The dose used in all cases initially was 1 mg. given slowly intravenously. The largest dose used was 3 mg. The .. Propranolol slowed the heart rate of patients in sinus rhythm as did pronethalol (Dornhorst and Robinson, 1962 (Hamer, Grandjean, Melendez and Sowton, 1964) , and in a double-blind trial using 20 patients Srivastava, Dewar and Newall (1964) (Paton, 1964) and in the treatment of hypertension (Prichard and Gillam, 1964 Pilkington, Lowe, Robinson and Titterington (1962) showed that the rise in plasma free fatty acids produced by adrenaline infusion was abolished by pronethalol but not by the alphareceptor blocking agent phenoxybenzamine. Recently Muir, Chamberlain and Pedroe (1964) showed that in short-term experiments prone- (Dornhorst and Robinson, 1962) and was found to precipitate heart failure on occasions (Stock and Dale, 1963 September, 1965 It was found to be of value in the reversion of supraventricular and ventricular tachycardia to sinus rhythm, but proved disappointing when given as prophylactic therapy to patients with paroxysmal arrhythmias. Similarly it proved ineffectual as a prophylactic drug to maintain sinus rhythm after DC shock reversion of atrial fibrillation.
Propranolol was effective in slowing the heart rate in both sinus tachycardia and atrial fibrillation and proved of benefit in patients with "effort syndrome."
In angina pectoris in a small uncontrolled series, results did not suggest that propranolol was of value.
In a further 50 patients given propranolol during anesthesia it was found to be of value in abolishing ventricular arrhythmias and in slowing the heart rate in certain circumstances.
The dangers of propranolol are immediate hypotensive reactions following parenteral use, notably in shocked subjects, and delayed hypotensive responses when used as long-term oral therapy, especially in patients with ischaemic heart disease. Heart failure may theoretically be aggravated by the drug and bronchospasm has been observed in asthmatic and bronchitic subjects under treatment.
Addendum.-Since this paper was written, propranolol has been used with apparent benefit in the following situation: a patient developed ventricular fibrillation associated with an acute coronary occlusion and was successfully reverted to sinus rhythm using internal DC defibrillation. However return of ventricular fibrillation occurred twice in the following twenty minutes requiring further DC shock. Intravenous propranolol (2 mg.) was then administered and sinus rhythm was maintained and the patient survived.
